These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 1583734
1. Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. Liu J, Perkins ND, Schmid RM, Nabel GJ. J Virol; 1992 Jun; 66(6):3883-7. PubMed ID: 1583734 [Abstract] [Full Text] [Related]
2. Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Duckett CS, Perkins ND, Kowalik TF, Schmid RM, Huang ES, Baldwin AS, Nabel GJ. Mol Cell Biol; 1993 Mar; 13(3):1315-22. PubMed ID: 8441377 [Abstract] [Full Text] [Related]
3. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB. Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036 [Abstract] [Full Text] [Related]
4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J. J Virol; 1996 Sep 18; 70(9):5777-85. PubMed ID: 8709193 [Abstract] [Full Text] [Related]
5. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Ganchi PA, Sun SC, Greene WC, Ballard DW. Mol Biol Cell; 1992 Dec 18; 3(12):1339-52. PubMed ID: 1493333 [Abstract] [Full Text] [Related]
6. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. La Rosa FA, Pierce JW, Sonenshein GE. Mol Cell Biol; 1994 Feb 18; 14(2):1039-44. PubMed ID: 8289784 [Abstract] [Full Text] [Related]
7. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Doerre S, Sista P, Sun SC, Ballard DW, Greene WC. Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069 [Abstract] [Full Text] [Related]
8. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR. Harhaj E, Blaney J, Millhouse S, Sun SC. Virology; 1996 Feb 01; 216(1):284-7. PubMed ID: 8615004 [Abstract] [Full Text] [Related]
9. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. Taylor JP, Pomerantz RJ, Raj GV, Kashanchi F, Brady JN, Amini S, Khalili K. J Virol; 1994 Jun 01; 68(6):3971-81. PubMed ID: 8189531 [Abstract] [Full Text] [Related]
12. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. Ramazzotti E, Vignoli M, Re MC, Furlini G, La Placa M. AIDS; 1996 May 01; 10(5):455-61. PubMed ID: 8724035 [Abstract] [Full Text] [Related]
13. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. González E, Punzón C, González M, Fresno M. J Immunol; 2001 Apr 01; 166(7):4560-9. PubMed ID: 11254713 [Abstract] [Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA. J Virol; 1997 Sep 01; 71(9):6486-94. PubMed ID: 9261367 [Abstract] [Full Text] [Related]
15. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. Cheng H, Tarnok J, Parks WP. J Virol; 1998 Aug 01; 72(8):6911-6. PubMed ID: 9658145 [Abstract] [Full Text] [Related]
16. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells. Kelly GD, Morris CB, Offermann MK. Virology; 1999 Oct 10; 263(1):128-38. PubMed ID: 10544088 [Abstract] [Full Text] [Related]
17. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. Shatrov VA, Boelaert JR, Chouaib S, Dröge W, Lehmann V. Eur Cytokine Netw; 1997 Mar 10; 8(1):37-43. PubMed ID: 9110146 [Abstract] [Full Text] [Related]
18. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, Venuta S. J Exp Med; 1994 Mar 01; 179(3):961-71. PubMed ID: 8113688 [Abstract] [Full Text] [Related]
19. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ. Nature; 1991 Aug 22; 352(6337):733-6. PubMed ID: 1876189 [Abstract] [Full Text] [Related]
20. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. Alcamí J, Laín de Lera T, Folgueira L, Pedraza MA, Jacqué JM, Bachelerie F, Noriega AR, Hay RT, Harrich D, Gaynor RB. EMBO J; 1995 Apr 03; 14(7):1552-60. PubMed ID: 7729429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]